David Weill

Director

David Weill (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in TransMedics Group, Inc. (TMDX). The largest single filing was $693K of TMDX (5,000 sh × $138.64, as filed), executed Dec 3 2025. The median gap between execution and disclosure was 3 days.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

purchases not yet priced

Delay-adjustediThe same average, entered at disclosure dates

–

purchases not yet priced

Filings, ttm

1 buys · 2 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.3M

shares × price, as filed

Last traded

Sep 11

Filed Sep 14

Median ADV $78.9M across their filed names

100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Open performance→

Volume by month

Buys $109K Sells $1.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

TMDX TransMedics Group, Inc. TMDX · 1 buy · 2 sells 3 filings

Recent filings

TMDXPURCHASE TransMedics Group, Inc. View filing → $109K
1,336 sh × $81.63
Exec Sep 11
Filed Sep 14 · 4:30 PM ET TMDXSALE TransMedics Group, Inc. View filing → $524K
3,571 sh × $146.82
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TMDXSALE TransMedics Group, Inc. View filing → $693K
5,000 sh × $138.64
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET